These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 14515043)

  • 1. [Factor V Leiden mutation and pregnancy complications].
    Abraitis V; Mongirdiene A; Mockeviciene A
    Medicina (Kaunas); 2003; 39(9):823-9. PubMed ID: 14515043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of factor V Leiden carriage on maternal and fetal health.
    Bloomenthal D; von Dadelszen P; Liston R; Magee L; Tsang P
    CMAJ; 2002 Jul; 167(1):48-54. PubMed ID: 12137081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor V Leiden mutation in pregnancy.
    Cohen SM
    J Obstet Gynecol Neonatal Nurs; 2004; 33(3):348-53. PubMed ID: 15180198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obstetric implications of the factor V leiden mutation: a review.
    Bloomenthal D; Delisle MF; Tessier F; Tsang P
    Am J Perinatol; 2002 Jan; 19(1):37-47. PubMed ID: 11857095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to activated protein C--frequent etiologic factor for venous thrombosis.
    Simkova M; Simko F; Kovacs L
    Bratisl Lek Listy; 2001; 102(5):240-7. PubMed ID: 11725376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anticoagulation and antiaggregation during pregnancy].
    Biasiutti FD; Strebel JK
    Ther Umsch; 2003 Jan; 60(1):54-8. PubMed ID: 12638480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thrombophilias and vascular placental pathology. A survey of the literature].
    Verspyck E; Marpeau L
    Rev Med Interne; 2005 Feb; 26(2):103-8. PubMed ID: 15710256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Factor V Leiden mutation. Successful outcome of a pregnancy after heparin therapy].
    Mazzarella CR; Del Bianco A; Pietropaolo F
    Minerva Ginecol; 2003 Feb; 55(1):81-5. PubMed ID: 12598848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pregnancy outcomes in a patient-heterozygous carrier of R506Q mutation of factor V (Leiden)].
    Herman M; Djelmis J; Troselj Z; Ivanisević M
    Acta Med Croatica; 2006 Jun; 60(3):277-80. PubMed ID: 16933843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obstetric implications of activated protein C resistance and factor V Leiden mutation.
    Gherman RB; Goodwin TM
    Obstet Gynecol Surv; 2000 Feb; 55(2):117-22. PubMed ID: 10674255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of factor V Leiden in maternal health and the outcome of pregnancy.
    Calderwood CJ; Greer IA
    Curr Drug Targets; 2005 Aug; 6(5):567-76. PubMed ID: 16026277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of thrombophylaxis on pregnancy outcome in patients with recurrent pregnancy loss associated with factor V Leiden mutation.
    Younis JS; Ohel G; Brenner B; Haddad S; Lanir N; Ben-Ami M
    BJOG; 2000 Mar; 107(3):415-9. PubMed ID: 10740341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor V Leiden: a review of the literature.
    Ament L
    J Perinat Neonatal Nurs; 2003; 17(3):190-5. PubMed ID: 12959480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism.
    Rodeghiero F; Tosetto A
    Ann Intern Med; 1999 Apr; 130(8):643-50. PubMed ID: 10215560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombophilias in pregnancy.
    Battinelli EM; Bauer KA
    Hematol Oncol Clin North Am; 2011 Apr; 25(2):323-33, viii. PubMed ID: 21444033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexistence of familial antiphospholipid syndrome and factor V Leiden: impact on thrombotic diathesis.
    Brenner B; Vulfsons SL; Lanir N; Nahir M
    Br J Haematol; 1996 Jul; 94(1):166-7. PubMed ID: 8757529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of the factor V Leiden mutation on pregnancy.
    Spina V; Aleandri V; Morini F
    Hum Reprod Update; 2000; 6(3):301-6. PubMed ID: 10874575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
    Martinelli I; Legnani C; Bucciarelli P; Grandone E; De Stefano V; Mannucci PM
    Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-based indications for thrombophilia screening.
    Lindhoff-Last E; Luxembourg B
    Vasa; 2008 Feb; 37(1):19-30. PubMed ID: 18512539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral venous thrombosis associated to homozygous factor V Leiden mutation in a female of Syrian origin.
    Mira Y; Alfaro A; Estellés A; Vayá A; Ferrando F; Villa P
    Haematologica; 2002 Jan; 87(1):ELT02. PubMed ID: 11801486
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.